Clinical Trial Update: Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for rituximab in people with psychosis and obsessive-compulsive disorder with suspected immune involvement; recruitment is ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brief Psychotic Disorder
• Delusional Disorder
• Obsessive-compulsive Disorder
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Uppsala University Hospital | Conditions: Obsessive-Compulsive Disorder, Obsessive-Compulsive Behavior | Phase 2 | Status: ENROLLING_BY_INVITATION